CTRI/2019/01/017088
Recruiting
未知
A pRospective, obsErvational, multicenter Study to evaluate cOmplications and treatmeNtmodAlities in Type-I diabEtes mellitus patients across India. - RESONATE- I
Aprica Healthcare Pvt Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E108- Type 1 diabetes mellitus with unspecified complications
- Sponsor
- Aprica Healthcare Pvt Ltd
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Participant/Legally Accepted Representatives/Parents/Guardians who are willing to provide written Informed Consent Form or participantâ??s LAR or guardian willing to provide written informed consent form
- •2\. Male or female of up to 35 years of age
- •3\.Diagnosed with type 1 diabetes mellitus based on clinical judgement and supported by laboratory analysis as per local guidelines
- •4\.Patients receiving injectable insulin or its analogue
Exclusion Criteria
- •1\. Past history of diabetic ketoacidosis requiring hospitalization within the last 90 days prior
- •to the baseline visit
- •2\. Patients with any other type of Diabetes except Type I Diabetes mellitus.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Observational study to evaluate safety and efficacy of fix dose combination of Metformin, glimePiride, and voglibose in Type 2 diabetes mellitus patientsHealth Condition 1: E118- Type 2 diabetes mellitus with unspecified complicationsCTRI/2019/01/017128Aprica Healthcare Pvt Ltd
Not yet recruiting
Phase 4
An Observational study to evaluate the safety and effectiveness of Rejoint Max® in Indian Patients with Osteoarthritis of KneeHealth Condition 1: M170- Bilateral primary osteoarthritis of kneeCTRI/2020/03/023852Abbott Healthcare Pvt Ltd
Recruiting
Not Applicable
Study to check safety and effectiveness of cilnidipine, metoprolol succinate and chlorthalidone in Indian hypertensive patients.Health Condition 1: I10- Essential (primary) hypertensionCTRI/2019/01/017089Aprica Healthcare Pvt Ltd
Recruiting
Phase 4
Observation on the efficacy of Tripterygium wilfordii polyglycosides tablets combined with Adamumab in the treatment of rheumatoid arthritisrheumatoid arthritisITMCTR2100005277The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Completed
Not Applicable
A Prospective, multicenter, observational study to identify deleterious novel variants of the DPYD gene in patients of non-Western descent: The DPYD-NOW studyCancer (breastcancercolorectal cancergastric cancer)10027656NL-OMON49023eids Universitair Medisch Centrum22